Part of a series which focuses on health economics and health services research, this volume discusses a variety of topics in the field.

The fields of pharmaceutical economics and health economics/policy are reaching a point of convergence. This is due to both the widespread availability of pharmaceutical treatments, accompanied by broader insurance coverage, and the regulation of prescription drugs in both private and government plans. This book will bridge the gap. We will explore developments in both U.S. and International setting. The system of the U.S. is characterized by a mix of private and government insurance for prescription drugs with the expansion of Medicare Part D. Most other developed countries are characterized by social insurance with either the government as a single payer such as in Canada or Australia, or a national health service as in many other European countries.

The book series "Contributions to Economic Analysis" was established under the editorship of Jan Tinbergen in 1952. Its purpose ever since has been to stimulate the international exchange of scientific information and to reinforce international cooperation by publishing original research in applied economics. The editors and authors of the series represent a broad range of geographic and subject matter interests in economics, and the series includes books from all areas of macroeconomics and microeconomics. These books have in common a quantitative approach to economic problems of practical importance.

Part of a series which focuses on health economics and health services research, this volume discusses topics including cost-benefit evaluations in mental health and the demand for health care for the treatment of mental problems among the elderly.

Obesity, which has increased in most developed countries in the past few decades, is the result of genetics, environment, and individual choices. Economics is useful for studying the individual choices that lead to obesity, explanations for the recent rise in obesity, the treatment options for obesity, and the costs and consequences of obesity for the individual and society.
The papers in this volume, devoted to the economics of obesity, illustrate the wide usefulness of the economic approach. The papers in the first section propose and test economic explanations for food-consumption choices and obesity. In particular, they assess the impact of food quality, access to fast food, food prices, legislation, and other factors on diet, physical activity, and body weight.
Treatments for obesity, specifically bariatric surgery and anti-obesity drugs, are studied in the second section of this volume. The third section is devoted to the labor market impacts of obesity; evidence from fifteen countries is presented and evaluated. The fourth and final section calculates the impact of obesity on hospital costs and examines the externalities imposed by obesity through health insurance.
Taken together, the papers in this volume advance the frontier of knowledge about the causes, implications, and consequences of obesity, and validate the usefulness of the economic approach for studying obesity in particular and medical conditions more generally.
*Studies obesity from an economic perspective
*Proposes economic explanation for food consumption choices, treatment of obesity, and treatment of the condition
*International in scope - provides evidence from 15 countries

Human capital is embodied in human beings. It embraces the individual's capacity to perform and enjoy activities that provide money and/or psychic income. Health behaviour affects human capital and is itself affected by the individual's human capital. This volume consists of original theoretical and empirical contributions to our knowledge of the interdependence between Human Capital and Health Behaviour.

Medical technology broadly defined to include all aspects of the process of treating disease (e.g., pharmaceuticals, medical devices, and surgical procedures) is profoundly important for individual health and, consequently, also for general welfare. Advances in medical technology convey the prospect of both improved population health and increased general welfare. However, because of the extensive regulation of the markets for healthcare goods and services, the development and application of medical technologies differs fundamentally from non-medical technological advances. In this volume of the "Advances in Health Economics and Health Services Research" series we present several papers that provide theoretical and empirical evidence about the market for medical technology.